Piperidine Market Size, Share, Opportunities, And Trends By Type (99% Purity, 98% Purity), By Application (Pharmaceutical, Agrochemicals, Rubber, Others), And By Geography - Forecasts From 2023 To 2028

  • Published : Aug 2023
  • Report Code : KSI061615933
  • Pages : 149

The piperidine market is estimated to grow at a CAGR of 7.08% during the forecast period.

Growing concerns about climate change and pollution have prompted decarbonization projects in a variety of businesses. Piperidine is being used in the production of chemicals, refinement, and heavy industrial operations as a result of a considerable shift away from conventional fuels and towards carbon-neutral alternatives. Moreover, the rapid rise in fuel prices, the rising pollution caused by the burning of fossil fuels, the rising investment in the research and development of cleaner energy alternatives, and the growing number of government initiatives to switch to clean energy sources are all expected to contribute to the increase in piperidine market size.

Increasing industrialization

In several sectors, including the pharmaceutical, chemical flavour, and fragrance industries, the Piperidine card is a sort of key facilitator. Because it serves as a fundamental building component for the increasing need for medications to treat a variety of disorders, piperidine is widely employed in pharmaceutical businesses for the creation of numerous medicines. Agrochemicals like insecticides and herbicides are produced using it, along with the pharmaceutical business. The use of piperidine in agriculture is growing as there is a larger need to boost agricultural productivity, more consumer demand for high-quality, organic foods, and government support for increasing agricultural produce.

Increased demand in the pharmaceutical industry

Piperidine derivatives are an important and diversified class of heterocyclic nitrogen molecules. There are numerous biological actions exhibited by substances with a piperidine moiety. A key ingredient in the production of many medications is piperidine. They are frequently present in drugs that are analgesic, anticancer, antibacterial, anti-inflammatory, and antipsychotic. Two of the most prevalent heterocyclic fragments in FDA-approved medications are the pyridine and piperidine complexes. In the synthesis of fine chemicals and active pharmaceutical ingredients (APIs), piperidine and its derivatives are frequently employed. The finished product is a typical organic substance or a structural component of numerous pharmaceutical intermediates.

Rising applications of 98% pure piperidine in the rubber industry and agrochemicals

Piperidine has a purity of 98 % and is largely employed in the synthesis of organic pesticides and herbicides as well as in the production of rubber. Piperidine is a component of the completed active ingredients of agrochemicals and is also utilised throughout manufacturing as a base, solvent, catalyst, or additional manufacturing aid. The relevant product plays a crucial role in the production of the plant growth regulator mepiquat, whose only application is on cotton. The main application for piperidine is the manufacture of elastomers. In contrast to inorganic vulcanizing accelerators, organic vulcanizing accelerators based on piperidine are simpler to dissolve into the rubber compound. P-Phenylenediamine (PPD) and pentamethylene thiuram tetra sulphate (DPTS), as well as ultra-accelerators and vulcanizing agents, are all produced from piperidine.

Increasing construction activities in variour sectors

Due to the rise of the pharmaceutical and agricultural sectors as a result of quick economic growth and government economic development programmes, piperidine is anticipated to be in high demand in emerging economies. By constructing manufacturing facilities, a number of manufacturers are deepening their entry into or growing their regional footprint. For instance, Avantor Inc. announced plans to create a new production and distribution hub in Singapore by combining its current distribution facility with new manufacturing operations. Owing to Singapore, Avantor will be better able to serve the rapidly expanding Asia Pacific biopharma sector which is increasing the piperidine market share.

The growing trend of biobased piperidine

The majority of people on the planet have recently adjusted their purchasing habits to favour more environmentally friendly and sustainable goods. So, the demand for biobased piperidine has increased as a result of the need for environmentally friendly and sustainable products. The use of biobased piperidine derivatives will probably continue as more businesses seek to create environmentally friendly products and lessen their environmental impact, particularly in developing nations which is expected to increase the piperidine market size during the forecast period.

Asia Pacific is projected to dominate the piperidine market

During the projected period, the Asia Pacific region is anticipated to lead the piperidine market. The Asia Pacific region has seen rapid economic expansion in a number of countries, including China, India, and Southeast Asian countries. The enhanced consumer spending power brought on by this economic success has increased demand for medications and other end uses based on piperidine. The Asia Pacific region's governments have put supportive measures in place to encourage indigenous manufacturing and draw in foreign capital. These regulations have helped a variety of sectors, notably the pharmaceutical and agrochemical industries, which are major Piperidine consumers, thrive. Government programmes like tax breaks, subsidies, and reduced regulatory regimes have benefited the region's piperidine market.

Market key launches

  • In August 2021, India Ratings and Research has maintained the Long-Term Issuer Rating of 'IND A+' for Vasudha Pharma Chem Limited (VPCL). VPCL has over two decades of experience manufacturing pharmaceutical intermediates and active pharmaceutical ingredients (APIs), in addition to enduring connections with significant clients. Large domestic and international pharmaceutical businesses with which VPCL has long-standing connections provide for a sizeable portion of its sales, primarily for its core compounds. The company has observed a consistent demand for these compounds over the past five years, and it anticipates that this demand will remain for the foreseeable future. The success of the company as described above is a result of all of the aforementioned elements as well as a number of other ones.
  • In August 2020, ESIM Chemicals' intermediates and specialty division, IM Chemicals, was acquired by Vertellus. It is a top supplier of chemical goods for the food, coatings, and lubricants industries. Vertellus strengthened its manufacturing capabilities in Europe and added additional markets to its specialised ingredients portfolio with the addition of IM Chemicals.


  • By Type
    • 99% Purity
    • 98% Purity
  • By Application
    • Pharmaceutical
    • Agrochemicals
    • Rubber
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline


2.1. Research Data

2.2. Assumptions


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. 99% Purity

5.3. 98% Purity


6.1. Introduction

6.2. Pharmaceutical

6.3. Agrochemicals

6.4. Rubber

6.5. Others


7.1. Introduction 

7.2. North America

7.2.1. USA

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. Germany

7.4.2. France

7.4.3. United Kingdom

7.4.4. Spain

7.4.5. Others

7.5. Middle East And Africa

7.5.1. Saudi Arabia

7.5.2. UAE

7.5.3. Israel

7.5.4. Others

7.6. Asia Pacific

7.6.1. China

7.6.2. Japan

7.6.3. India

7.6.4. South Korea

7.6.5. Indonesia

7.6.6. Taiwan

7.6.7. Others


8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix


9.1. Alfa Aesar

9.2. BASF SE

9.3. Corey Organics

9.4. Jubilant Ingrevia Limited

9.5. Koei Chemical Co. Ltd.

9.6. Lanxess AG

9.7. Merck KGaA

9.8. Taj Pharmaceuticals Ltd.

9.9. Vertellus

9.10. SimSon Pharma 

Alfa Aesar


Corey Organics

Jubilant Ingrevia Limited

Koei Chemical Co. Ltd.

Lanxess AG

Merck KGaA

Taj Pharmaceuticals Ltd.


SimSon Pharma